Imaging modalities for the diagnosis and disease activity assessment of Takayasu's arteritis: A systematic review and meta-analysis

被引:108
作者
Barra, Lillian [1 ]
Kanji, Tahir [1 ]
Malette, Jacqueline [1 ]
Pagnoux, Christian [2 ]
机构
[1] Univ Western Ontario, Dept Microbiol & Immunol, Dept Med, Div Rheumatol, 268 Grosvenor St, London, ON N6H 4V2, Canada
[2] Mt Sinai Hosp, Dept Med, Div Rheumatol, 60 Murray St, Toronto, ON M5T 3L9, Canada
关键词
Takayasu's arteritis; Aortitis; Large vessel vasculitis; Imaging; CT; MR; PET; Ultrasound; LARGE-VESSEL VASCULITIS; B-MODE ULTRASONOGRAPHY; ELECTRON-BEAM CT; FDG PET-CT; MAGNETIC-RESONANCE; MR-ANGIOGRAPHY; MURAL CHANGES; FOLLOW-UP; EMISSION-TOMOGRAPHY; PULMONARY-ARTERY;
D O I
10.1016/j.autrev.2017.11.021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Early diagnosis of Takayasu's Arteritis (TAK) and detection of disease activity may reduce the risk of vascular complications. The objective of this study was to determine the effectiveness of imaging modalities for the management of TAK. Methods: MEDLINE and EMBASE were searched for studies of patients undergoing various imaging modalities for TAK diagnosis or to assess disease activity. We excluded case reports, reviews and case series with < 10 patients. The methodologic quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). Random effects meta-analyses with inverse-variance weighting were performed. Results: From the 1126 citations screened, 57 studies met our inclusion criteria. Many of the studies were of small sample size (average N = 27), cross-sectional design and low methodological quality. Ultrasound (US) had a lower pooled sensitivity (SN) of 81% (95% CI: 69-89%) than Magnetic Resonance Angiography (MRA) with SN = 92% (95% CI: 88-95%) for TAK diagnosis (by clinical criteria and/or X-Ray angiography). Both had high specificities (SP) of > 90% for TAK diagnosis. Fewer studies investigated computed tomography angiography (CTA), but SN and SP for TAK diagnosis was high (> 90%). The utility of vessel wall thickening and enhancement by MRA and CTA to predict disease activity varied across studies. The pooled SN and SP of F-18-fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) for disease activity was 81% (95% CI: 69-89%) and 74% (95% CI: 55-86%), respectively. Conclusion: US, CTA and/or MRA are effective for the diagnosis of TAK. The utility of these imaging modalities for assessing disease activity remains unclear. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:175 / 187
页数:13
相关论文
共 70 条
[11]  
2-Y
[12]   Patterns of aortic involvement in Takayasu arteritis and its clinical implications: Evaluation with spiral computed tomography angiography [J].
Chung, Jin Wook ;
Kim, Hyo-Cheol ;
Choi, Young Ho ;
Kim, Sang Joon ;
Lee, Whal ;
Park, Jae Hyung .
JOURNAL OF VASCULAR SURGERY, 2007, 45 (05) :906-914
[13]   The limited role of MRI in long-term follow-up of patients with Takayasu's arteritis [J].
Eshet, Yael ;
Pauzner, Rachel ;
Goitein, Orly ;
Langevitz, Pnina ;
Eshed, Iris ;
Hoffmann, Chen ;
Konen, Eli .
AUTOIMMUNITY REVIEWS, 2011, 11 (02) :132-136
[14]   Altered Flow-Mediated Vasodilatation, Low Paraoxonase-1 Activity, and Abnormal High-Density Lipoprotein Subclass Distribution in Takayasu's Arteritis [J].
Espinola-Zavaleta, Nilda ;
Elena Soto-Lopez, Maria ;
Carreon-Torres, Elizabeth ;
Gamboa, Ricardo ;
Mejia, Ana M. ;
Marquez-Velasco, Ricardo ;
Bojalil, Rafael ;
Huesca-Gomez, Claudia ;
Reyes, Pedro A. ;
Perez-Mendez, Oscar .
CIRCULATION JOURNAL, 2009, 73 (04) :760-766
[15]  
Fan WT, 2016, INT ANGIOL, V35, P586
[16]   Diagnostic value of 3D contrast-enhanced magnetic resonance angiography in Takayasu's arteritis-a comparative study with digital subtraction angiography [J].
Garg, Shobhit K. ;
Mohan, Suyash ;
Kumar, Sunil .
EUROPEAN RADIOLOGY, 2011, 21 (08) :1658-1666
[17]   Magnetic resonance imaging of vascular changes in Takayasu arteritis [J].
Hata, A ;
Numano, F .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 52 (01) :45-52
[18]   Estimating the mean and variance from the median, range, and the size of a sample [J].
Hozo S.P. ;
Djulbegovic B. ;
Hozo I. .
BMC Medical Research Methodology, 5 (1)
[19]  
Ihata A, 2013, ANN RHEUM DIS C ANN, V72
[20]  
Incerti E, 2014, EUR J NUCL MED MOL I, V41, pS296